272 related articles for article (PubMed ID: 36303552)
1. Pathogenic variants of ornithine transcarbamylase deficiency: Nation-wide study in Japan and literature review.
Kido J; Sugawara K; Sawada T; Matsumoto S; Nakamura K
Front Genet; 2022; 13():952467. PubMed ID: 36303552
[TBL] [Abstract][Full Text] [Related]
2. Late-Onset Ornithine Transcarbamylase Deficiency and Variable Phenotypes in Vietnamese Females With
Nguyen HH; Khanh Nguyen N; Dung Vu C; Thu Huong Nguyen T; Nguyen NL
Front Pediatr; 2020; 8():321. PubMed ID: 32793520
[No Abstract] [Full Text] [Related]
3. Father-to-daughter transmission in late-onset OTC deficiency: an underestimated mechanism of inheritance of an X-linked disease.
Siri B; Olivieri G; Lepri FR; Poms M; Goffredo BM; Commone A; Novelli A; Häberle J; Dionisi-Vici C
Orphanet J Rare Dis; 2024 Jan; 19(1):3. PubMed ID: 38167094
[TBL] [Abstract][Full Text] [Related]
4. Induced pluripotent stem cell technology as diagnostic tool in patients with suspected ornithine transcarbamylase deficiency lacking genetic confirmation.
Ramosaj A; Singhal P; Schaller A; Laemmle A
Mol Genet Metab Rep; 2023 Dec; 37():101007. PubMed ID: 38053928
[TBL] [Abstract][Full Text] [Related]
5. Hyperammonemia crisis following parturition in a female patient with ornithine transcarbamylase deficiency.
Kido J; Kawasaki T; Mitsubuchi H; Kamohara H; Ohba T; Matsumoto S; Endo F; Nakamura K
World J Hepatol; 2017 Feb; 9(6):343-348. PubMed ID: 28293384
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the total number of disease-causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential.
Arranz JA; Riudor E; Marco-Marín C; Rubio V
J Inherit Metab Dis; 2007 Apr; 30(2):217-26. PubMed ID: 17334707
[TBL] [Abstract][Full Text] [Related]
7. A promoter variant in the OTC gene associated with late and variable age of onset hyperammonemia.
Han ST; Anderson KJ; Bjornsson HT; Longo N; Valle D
J Inherit Metab Dis; 2022 Jul; 45(4):710-718. PubMed ID: 35605046
[TBL] [Abstract][Full Text] [Related]
8. An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency.
Scaglia F; Zheng Q; O'Brien WE; Henry J; Rosenberger J; Reeds P; Lee B
Pediatrics; 2002 Jan; 109(1):150-2. PubMed ID: 11773558
[TBL] [Abstract][Full Text] [Related]
9. Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency.
Wakiya T; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Ushijima K; Otomo S; Sakamoto K; Murayama K; Takayanagi M; Hakamada K; Yasuda Y; Mizuta K
Mol Genet Metab; 2012 Mar; 105(3):404-7. PubMed ID: 22264779
[TBL] [Abstract][Full Text] [Related]
10. Mutation Study of Malaysian Patients with Ornithine Transcarbamylase Deficiency: Clinical, Molecular, and Bioinformatics Analyses of Two Novel Missense Mutations of the
Ali EZ; Zakaria Y; Mohd Radzi MA; Ngu LH; Jusoh SA
Biomed Res Int; 2018; 2018():4320831. PubMed ID: 30175132
[TBL] [Abstract][Full Text] [Related]
11. The phenotypic and mutational spectrum of Thai female patients with ornithine transcarbamylase deficiency.
Chongsrisawat V; Damrongphol P; Ittiwut C; Ittiwut R; Suphapeetiporn K; Shotelersuk V
Gene; 2018 Dec; 679():377-381. PubMed ID: 30223008
[TBL] [Abstract][Full Text] [Related]
12. Disease-causing mutations in the promoter and enhancer of the ornithine transcarbamylase gene.
Jang YJ; LaBella AL; Feeney TP; Braverman N; Tuchman M; Morizono H; Ah Mew N; Caldovic L
Hum Mutat; 2018 Apr; 39(4):527-536. PubMed ID: 29282796
[TBL] [Abstract][Full Text] [Related]
13. Corticosteroid suppresses urea-cycle-related gene expressions in ornithine transcarbamylase deficiency.
Imoto K; Tanaka M; Goya T; Aoyagi T; Takahashi M; Kurokawa M; Tashiro S; Kato M; Kohjima M; Ogawa Y
BMC Gastroenterol; 2022 Mar; 22(1):144. PubMed ID: 35346058
[TBL] [Abstract][Full Text] [Related]
14. Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database.
Sen K; Izem R; Long Y; Jiang J; Konczal LL; McCarter RJ; ; Gropman AL; Bedoyan JK
Mol Genet Genomic Med; 2024 Apr; 12(4):e2443. PubMed ID: 38634223
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and Management Issues in Patients with Late-Onset Ornithine Transcarbamylase Deficiency.
Ibrahim MS; Gold JI; Woodall A; Yilmaz BS; Gissen P; Stepien KM
Children (Basel); 2023 Aug; 10(8):. PubMed ID: 37628367
[TBL] [Abstract][Full Text] [Related]
16. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
[TBL] [Abstract][Full Text] [Related]
17. [Consensus on diagnosis and treatment of ornithine trans-carbamylase deficiency].
Division of Genetics and Metabolism, Child Diseases and Health Care Branch, Chinese Association for Maternal and Child Health
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 49(5):539-547. PubMed ID: 33210478
[TBL] [Abstract][Full Text] [Related]
18. Hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency due to a novel combined heterozygous mutations.
Gao J; Gao F; Hong F; Yu H; Jiang P
Am J Emerg Med; 2015 Mar; 33(3):474.e1-3. PubMed ID: 25227973
[TBL] [Abstract][Full Text] [Related]
19. In Silico Analysis of a De Novo OTC Variant as a Cause of Ornithine Transcarbamylase Deficiency.
Ozdemir Y; Cag M; Gul S; Yüksel Z; Ergoren MC
Appl Immunohistochem Mol Morphol; 2022 Feb; 30(2):153-156. PubMed ID: 34670952
[TBL] [Abstract][Full Text] [Related]
20. Ornithine transcarbamylase deficiency unmasked because of gastrointestinal bleeding.
Trivedi M; Zafar S; Spalding MJ; Jonnalagadda S
J Clin Gastroenterol; 2001 Apr; 32(4):340-3. PubMed ID: 11276280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
